Jeroen H J Paulissen (J H J Paulissen)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Topics

Molecularly Imprinted

Health Insurance

Simultaneous Determination

Top Venues

Journal of medical economics

The European journal of health economics : HEPAC : health economics in prevention and care

This page only lists publications with an associated author ORCID identifier.

Publications

Sara W Quist, Jeroen H J Paulissen, D N J Wyndaele, James Nagarajah, Roel D Freriks
Costs of radium-223 and the pharmacy preparation 177 Lu-PSMA-I&T for metastatic castration-resistant prostate cancer in Dutch hospitals. Journal of medical economics 26 (1) (2023)
Sara W Quist, Jeroen H J Paulissen, D N J Wyndaele, James Nagarajah, Roel D Freriks
Costs of radium-223 and the pharmacy preparation 177 Lu-PSMA-I&T for metastatic castration-resistant prostate cancer in Dutch hospitals. Journal of medical economics 26 (1) (2023)
Jeroen H J Paulissen, Ahmed H Seddik, Kyle J Dunton, Christopher J Livings, Marinus H van Hulst, Maarten Jacobus Postma, Lisa Aniek de Jong, Roel D Freriks
Cost-effectiveness model of trastuzumab deruxtecan as second-line treatment in HER2-positive unresectable and/or metastatic breast cancer in Finland. The European journal of health economics : HEPAC : health economics in prevention and care (2023)